Viewing Study NCT03366350


Ignite Creation Date: 2025-12-24 @ 4:48 PM
Ignite Modification Date: 2026-04-22 @ 4:51 PM
Study NCT ID: NCT03366350
Status: UNKNOWN
Last Update Posted: 2019-05-10
First Post: 2017-12-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies
Sponsor: Wuhan Sian Medical Technology Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module